Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation – summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019

Concerning development of medicinal products, children belong to a so-called “special population” for which additional legislation applies: Regulation (EC) No 1901/2006 on medicinal products for paediatric use sets up a system of requirements, rewards and incentives to ensure that medicinal products...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Allergy
Main Authors: Mahler, V., Mentzer, D., Bonertz, A., Muraro, A., Eigenmann, P., Bousquet, J., Halken, S., Pfaar, O., Jutel, M., Wahn, U., Vieths, S., Kaul, S.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7325268/
https://ncbi.nlm.nih.gov/pubmed/32612805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-020-00327-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados